company background image
ZTS logo

Zoetis NYSE:ZTS Stock Report

Last Price

US$153.11

Market Cap

US$70.0b

7D

-5.9%

1Y

-12.2%

Updated

18 Apr, 2024

Data

Company Financials +

ZTS Stock Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally.

ZTS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance5/6
Financial Health4/6
Dividends4/6

Narratives

Beta

Narratives bring a range of perspectives from our community.

Zoetis Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zoetis
Historical stock prices
Current Share PriceUS$153.11
52 Week HighUS$201.92
52 Week LowUS$148.48
Beta0.85
1 Month Change-11.48%
3 Month Change-18.72%
1 Year Change-12.21%
3 Year Change-9.44%
5 Year Change50.36%
Change since IPO393.74%

Recent News & Updates

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Apr 15

Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Apr 12
Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Recent updates

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Apr 15

Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Apr 12
Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Zoetis: My Favorite Healthcare Stock Right Now

Mar 21

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Mar 03
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness

Feb 27

Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns

Jan 10

Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Jan 01
Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Dec 06
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Nov 18
Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Zoetis: High-Quality Compounder With A Reasonable Price After Earnings

Nov 09

Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now

Oct 26

Zoetis Is An Impressive Healthcare Compounder

Sep 26

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Sep 25
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Sep 04
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.

Aug 22

Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Aug 12
Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Zoetis: My Dog Approves Of This Dividend Compounder

Jul 19

Zoetis: A Purrfect Addition To Your Portfolio

Jun 22

Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

Jun 10
Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Mar 10
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus

Feb 14

Zoetis Is An Awesome Dividend Growth Stock

Jan 17

It's A Great Time To Buy Zoetis Shares

Jan 10

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Jan 03
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Dec 29
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Zoetis raises quarterly dividend by 15.4% to $0.375/share

Dec 08

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Nov 20
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis' Q3 Earnings: Supply Issues Putting A Dent On Growth

Nov 08

Zoetis Q3 2022 Earnings Preview

Nov 02

Does Zoetis (NYSE:ZTS) Deserve A Spot On Your Watchlist?

Nov 02
Does Zoetis (NYSE:ZTS) Deserve A Spot On Your Watchlist?

Zoetis declares $0.325 dividend

Oct 13

A Rising Dollar May Mean Lower Zoetis Shares

Oct 07

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Sep 15
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Zoetis cleared to acquire Jurox in Australia subject to divestiture

Sep 15

Zoetis acquires Scottish animal health digital tech business

Sep 05

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 21%?

Aug 19
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 21%?

Zoetis: Strong Q2 Underlying Growth But Hit By Strong U.S. Dollar

Aug 12

Zoetis Q2 2022 Earnings Preview

Aug 03

Zoetis: Lovable Company With Vision

Jul 20

Shareholder Returns

ZTSUS PharmaceuticalsUS Market
7D-5.9%-2.3%-3.7%
1Y-12.2%11.4%20.2%

Return vs Industry: ZTS underperformed the US Pharmaceuticals industry which returned 11.4% over the past year.

Return vs Market: ZTS underperformed the US Market which returned 20.2% over the past year.

Price Volatility

Is ZTS's price volatile compared to industry and market?
ZTS volatility
ZTS Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement9.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: ZTS's share price has been volatile over the past 3 months.

Volatility Over Time: ZTS's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195214,100Kristin Peckwww.zoetis.com

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives.

Zoetis Inc. Fundamentals Summary

How do Zoetis's earnings and revenue compare to its market cap?
ZTS fundamental statistics
Market capUS$69.96b
Earnings (TTM)US$2.34b
Revenue (TTM)US$8.54b

29.8x

P/E Ratio

8.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZTS income statement (TTM)
RevenueUS$8.54b
Cost of RevenueUS$2.56b
Gross ProfitUS$5.99b
Other ExpensesUS$3.64b
EarningsUS$2.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 02, 2024

Earnings per share (EPS)5.13
Gross Margin70.06%
Net Profit Margin27.43%
Debt/Equity Ratio132.1%

How did ZTS perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

30%

Payout Ratio

Does ZTS pay a reliable dividends?

See ZTS dividend history and benchmarks
When do you need to buy ZTS by to receive an upcoming dividend?
Zoetis dividend dates
Ex Dividend DateApr 18 2024
Dividend Pay DateJun 04 2024
Days until Ex dividend2 days
Days until Dividend pay date45 days

Does ZTS pay a reliable dividends?

See ZTS dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.